FMC Corp (FMC) reported quarterly earnings results on Tuesday, Aug-2-2016. The company said it had a profit of $0.69 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.01. Analysts had a consensus of $0.68. The company posted revenue of $810.30 million in the period, compared to analysts expectations of $894.31 million. The company’s revenue was down -8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS.
FMC Corp closed down -0.52 points or -1.08% at $47.54 with 10,61,391 shares getting traded on Friday. Post opening the session at $47.79, the shares hit an intraday low of $46.8 and an intraday high of $47.79 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Investors should note that on Jul 20, 2016, FMC Corp announced a cash dividend of $0.1650. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 20, 2016.
In a different news, on Jun 15, 2016, Andrea E Utecht (Exec. VP, General Counsel, Sec) sold 14,388 shares at $48.72 per share price. According to the SEC, on Mar 4, 2016, Mark Douglas (Pres. Agricultural Solutions) sold 10,480 shares at $38.22 per share price. On Sep 3, 2015, Paul W Graves (CFO) purchased 3,342 shares at $40.84 per share price, according to the Form-4 filing with the securities and exchange commission.
FMC Corporation is a diversified chemical company. The Company serves agricultural consumer and industrial markets with solutions applications and products around the world. The Company operates in three business segments: FMC Agricultural Solutions FMC Health and Nutrition and FMC Lithium. The Company’s FMC Agricultural Solutions segment develops markets and sells three classes of crop protection chemicals which include insecticides herbicides and fungicides. The FMC Health and Nutrition segment focuses on food pharmaceutical ingredients nutraceuticals personal care and similar markets. The pharmaceutical additives are used for binding encapsulation and disintegrant applications. The Company’s FMC Lithium segment manufactures lithium products.